Endocannabinoid and mood responses to exercise in adults with varying activity levels

Medicine and Science in Sports and Exercise

Volumn 49, Issue 8, 2017, Pages 1688-1696

  Brellenthin, Angelique G ^a   Crombie, Kevin M ^a   Hillard, Cecilia J ^b   Koltyn, Kelli F ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

2 arachidonoylglycerol; Anandamide; Anxiety; Depression; Preferred; Self selected

Indexed keywords

ACYLGLYCEROL; ARACHIDONIC ACID DERIVATIVE; ENDOCANNABINOID; GLYCERYL 2-ARACHIDONATE; N-ARACHIDONOYLETHANOLAMINE;

AFFECT; BLOOD; EXERCISE; FEMALE; HUMAN; MALE; PHYSIOLOGY; PSYCHOLOGY; YOUNG ADULT;

AFFECT; ARACHIDONIC ACIDS; ENDOCANNABINOIDS; EXERCISE; FEMALE; GLYCERIDES; HUMANS; MALE; YOUNG ADULT;

EID: 85015696439     PISSN: 01959131     EISSN: 15300315     Source Type: Journal    
DOI: 10.1249/MSS.0000000000001276     Document Type: Article

References (55)

1. Antunes HK, Leite GS, Lee KS, et al. Exercise deprivation increases negative mood in exercise-addicted subjects and modifies their biochemical markers. Physiol Behav. 2016;156:182-90.
2. Biedermann SV, Auer MK, Bindila L, et al. Restricted vs. unrestricted wheel running in mice: effects on brain, behavior and endocannabinoids. Horm Behav. 2016;86:45-54.
3. Borg G. Borg's Perceived Exertion and Pain Scales. Human Kinetics: Champaign (IL); 1998. pp. 104.
4. Boutcher SH, Landers DM. The effects of vigorous exercise on anxiety, heart rate, and alpha activity of runners and nonrunners. Psychophysiology. 1988;25(6):696-702.
5. Cedernaes J, Fanelli F, Fazzini A, et al. Sleep restriction alters plasma endocannabinoids concentrations before but not after exercise in humans. Psychoneuroendocrinology. 2016;74:258-68.
6. Christensen R, Kristensen PK, Bartels EM, Bliddal H, Astrup A. Efficacy and safety of the weight-loss drug rimonabant: a metaanalysis of randomised trials. Lancet. 2007;370(9600):1706-13.
7. Davis C, Brewer H, Ratusny D. Behavioral frequency and psychological commitment: necessary concepts in the study of excessive exercising. J Behav Med. 1993;16(6):611-28.
8. De Chiara V, Errico F, Musella A, et al. Voluntary exercise and sucrose consumption enhance cannabinoid CB1 receptor sensitivity in the striatum. Neuropsychopharmacology. 2010;35(2):374-87.
9. Dietrich A, McDaniel WF. Endocannabinoids and exercise. Br J Sports Med. 2004;38(5):536-41.
10. Dishman RK, Farquhar RP, Cureton KJ. Responses to preferred intensities of exertion in men differing in activity levels. Med Sci Sports Exerc. 1994;26(6):783-90.
11. Dubreucq S, Durand A, Matias I, et al. Ventral tegmental area cannabinoid type-1 receptors control voluntary exercise performance. Biol Psychiatry. 2013;73(9):895-903.
12. Dubreucq S, Koehl M, Abrous DN, Marsicano G, Chaouloff F. CB1 receptor deficiency decreases wheel-running activity: consequences on emotional behaviours and hippocampal neurogenesis. Exp Neurol. 2010;224(1):106-13.
13. Fernández-Aranda F, Sauchelli S, Pastor A, et al. Moderate-vigorous physical activity across body mass index in females: moderating effect of endocannabinoids and temperament. PLoS One. 2014;9(8):e104534.
14. Feuerecker M, Hauer D, Toth R, et al. Effects of exercise stress on the endocannabinoid system in humans under field conditions. Eur J Appl Physiol. 2012;112(7):2777-81.
15. Franklin BA, Whaley MH, Howley ET, Balady GJ. ACSM's Guidelines for Exercise Testing and Prescription. 6th ed. Philadelphia (PA): Lippincott Williams & Wilkins; 2000. p. 368.
16. Fuss J, Gass P. Endocannabinoids and voluntary activity in mice: runner's high and long-term consequences in emotional behaviors. Exp Neurol. 2010;224(1):103-5.
17. Fuss J, Steinle J, Bindila L, et al. A runner's high depends on cannabinoid receptors in mice. Proc Natl Acad Sci U S A. 2015;112(42): 13105-8.
18. Galdino G, Romero T, Silva JF, et al. Acute resistance exercise induces antinociception by activation of the endocannabinoid system in rats. Anesth Analg. 2014;119:702-15.
19. Gasperi V, Ceci R, Tantimonaco M, et al. The fatty acid amide hydrolase in lymphocytes from sedentary and active subjects. Med Sci Sports Exerc. 2014;46(1):24-32.
20. Hallgren MA, Moss ND, Gastin P. Regular exercise participation mediates the affective response to acute bouts of vigorous exercise. J Sports Sci Med. 2010;9(4):629-37.
21. Hanlon EC, Tasali E, Leproult R, et al. Circadian rhythm of circulating levels of the endocannabinoid 2-arachidonoylglycerol. J Clin Endocrinol Metab. 2015;100(1):220-6.
22. Hazell TJ, Islam H, Townsend LK, Schmale MS, Copeland JL. Effects of exercise intensity on plasma concentrations of appetiteregulating hormones: potential mechanisms. Appetite. 2016;98:80-8.
23. Heyman E, Gamelin FX, GoekintM, et al. Intense exercise increases circulating endocannabinoid and BDNF levels in humans-possible implications for reward and depression. Psychoneuroendocrinology. 2012;37(6):844-51.
24. Heyward VH. The physical fitness specialist certification manual: the Cooper Institute for Aerobics Research. In: Advance Fitness Assessment & Exercise Prescription. 3rd ed. Dallas (TX): Human Kinetics; 1998. p. 48.
25. Hill MN, Patel S. Translational evidence for the involvement of the endocannabinoid system in stress-related psychiatric illnesses. Biol Mood Anxiety Disord. 2013;3(1):19.
26. Hill MN, Patel S, Campolongo P, Tasker JG, Wotjak CT, Bains JS. Functional interactions between stress and the endocannabinoid system: from synaptic signaling to behavioral output. J Neurosci. 2010;30(45):14980-6.
27. Hillard CJ. The endocannabinoid signaling system in the CNS: a primer. Int Rev Neurobiol. 2015;125:1-47.
28. Justinova Z, Solinas M, Tanda G, Redhi GH, Goldberg SR. The endogenous cannabinoid anandamide and its synthetic analog R(+)-methanandamide are intravenously self-administered by squirrel monkeys. J Neurosci. 2005;25(23):5645-50.
29. Justinová Z, Yasar S, Redhi GH, Goldberg SR. The endogenous cannabinoid 2-arachidonoylglycerol is intravenously self-administered by squirrel monkeys. J Neurosci. 2011;31(19):7043-8.
30. Kargotich S, Goodman C, Keast D, et al. Influence of exerciseinduced plasma volume changes on the interpretation of biochemical data following high-intensity exercise. Clin J Sport Med. 1997;7(3): 185-91.
31. Keeney BK, Meek TH, Middleton KM, Holness LF, Garland T. Sex differences in cannabinoid receptor-1 (CB1) pharmacology in mice selectively bred for high voluntary wheel-running behavior. Pharmacol Biochem Behav. 2012;101(4):528-37.
32. Koltyn KF, Brellenthin AG, Cook DB, Sehgal N, Hillard C. Mechanisms of exercise-induced hypoalgesia. J Pain. 2014;15(12): 1294-304.
33. Lee HH, Emerson JA, Williams DM. Exercise, affect, and adherence: an evolutionary perspective. Front Psychol. 2016;7:1285.
34. Maldonado R, Valverde O, Berrendero F. Involvement of the endocannabinoid system in drug addiction. Trends Neurosci. 2006;29(4): 225-32.
35. Mattace Raso G, Russo R, Calignano A, Meli R. Palmitoylethanolamide in CNS health and disease. Pharmacol Res. 2014;86:32-41.
36. McNair D, Lorr M, Droppleman LF. Revised Manual for the Profile of Mood States. Educational and Industrial Testing Service: San Diego (CA); 1992. p. 40.
37. Miller AH, Raison CL. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol. 2015;16(1):22-34.
38. Parfitt G, Rose EA, Burgess WM. The psychological and physiological responses of sedentary individuals to prescribed and preferred intensity exercise. Br J Health Psychol. 2006;11(Pt 1):39-53.
39. Petruzzello SJ, Jones AC, Tate AK. Affective responses to acute exercise: a test of opponent-process theory. J Sports Med Phys Fitness. 1997;37(3):205-12.
40. Physical Activity Guidelines Advisory Committee. 2008 Physical Activity Guidelines for Americans. Washington (DC): U.S. Department of Health and Human Services; 2008. p. 76. Available from: https://health.gov/paguidelines/pdf/paguide.pdf.
41. Raichlen DA, Foster AD, Gerdeman GL, Seillier A, Giuffrida A. Wired to run: exercise-induced endocannabinoid signaling in humans and cursorial mammals with implications for the ''runner's high.'' J Exp Biol. 2012;215:1331-6.
42. Raichlen DA, Foster AD, Seillier A, Giuffrida A, Gerdeman GL. Exercise-induced endocannabinoid signaling is modulated by intensity. Eur J Appl Physiol. 2013;113(4):869-75.
43. Rasmussen EB, Hillman C. Naloxone and rimonabant reduce the reinforcing properties of exercise in rats. Exp Clin Psychopharmacol. 2011;19(6):389-400.
44. Reed J, Berg KE, Latin RW, La Voie JP. Affective responses of physically active and sedentary individuals during and after moderate aerobic exercise. J Sports Med Phys Fitness. 1998;38(3):272-8.
45. Richardson MT, Ainsworth BE, Jacobs DR, Leon AS. Validation of the Stanford 7-Day Recall to Assess Habitual Physical Activity. Ann Epidemiol. 2001;11(2):145-53.
46. Romano A, Tempesta B, Provensi G, Passani MB, Gaetani S. Central mechanisms mediating the hypophagic effects of oleoylethanolamide and N-acylphosphatidylethanolamines: different lipid signals? Front Pharmacol. 2015;6:137.
47. Rose EA, Parfitt G. Exercise experience influences affective and motivational outcomes of prescribed and self-selected intensity exercise. Scand J Med Sci Sports. 2012;22(2):265-77.
48. Sallis JF, Haskell WL, Wood PD, et al. Physical activity assessment methodology in the Five-City Project. Am J Epidemiol. 1985;121(1): 91-106.
49. Sloane R, Snyder DC, Demark-Wahnefried W, Lobach D, Kraus WE. Comparing the 7-Day Physical Activity Recall with a triaxial accelerometer for measuring time in exercise. Med Sci Sports Exerc. 2009;41(6):1334-40.
50. Sparling PB, Giuffrida A, Piomelli D, Rosskopf L, Dietrich A. Exercise activates the endocannabinoid system. Neuroreport. 2003; 14(17):2209-11.
51. Spielberger CD, Gorsuch RL, Lushene PR, et al. Manual for the State-Trait Anxiety Inventory. Sunnyvale, CA: Consulting Psychologists Press, Inc.; 1983. p. 84.
52. Terry PC, Lane AM. Normative values for the Profile of Mood States for use with athletic samples. J Appl Sport Psychol. 2000;12(1):93-109.
53. Tsatsoulis A, Fountoulakis S. The protective role of exercise on stress system dysregulation and comorbidities. Ann N Y Acad Sci. 2006;1083:196-213.
54. Vaughn LK, Denning G, Stuhr KL, De Wit H, Hill MN, Hillard CJ. Endocannabinoid signalling: has it got rhythm? Br J Pharmacol. 2010;160(3):530-43.
55. Wardwell KK, Focht BC, Courtney Devries A, O'connell AA, Buckworth J. Affective responses to self-selected and imposed walking in inactive women with high stress: a pilot study. J Sports Med Phys Fitness. 2013;53(6):701-12.